By expenditures
| Name | Title | Type |
|---|---|---|
| Stephen Curley | Comptroller | Auditee |
| Matthew Scott Hunt | Signing Director | Auditee |
| Jim Piotrowski | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351352 | 2024 | 2025-03-31 | Cliftonlarsonallen LLP (cla) | $25.18M |
| 299250 | 2023 | 2024-03-28 | Cliftonlarsonallen LLP (cla) | $23.04M |
| 51750 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $38.56M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 351352 | 2024 | 2025-03-31 | 1123420 | 2024-005 | Significant Deficiency | - | L |
| 351352 | 2024 | 2025-03-31 | 1123419 | 2024-004 | Significant Deficiency | - | AB |
| 351352 | 2024 | 2025-03-31 | 1123418 | 2024-003 | Significant Deficiency | - | M |
| 351352 | 2024 | 2025-03-31 | 1123417 | 2024-002 | Material Weakness | - | L |
| 351352 | 2024 | 2025-03-31 | 1123416 | 2024-001 | Significant Deficiency | - | I |
| 351352 | 2024 | 2025-03-31 | 546978 | 2024-005 | Significant Deficiency | - | L |
| 351352 | 2024 | 2025-03-31 | 546977 | 2024-004 | Significant Deficiency | - | AB |
| 351352 | 2024 | 2025-03-31 | 546976 | 2024-003 | Significant Deficiency | - | M |
| 351352 | 2024 | 2025-03-31 | 546975 | 2024-002 | Material Weakness | - | L |
| 351352 | 2024 | 2025-03-31 | 546974 | 2024-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 963373 | 2023-004 | Material Weakness | - | N |
| 299250 | 2023 | 2024-03-28 | 963372 | 2023-003 | Material Weakness | - | M |
| 299250 | 2023 | 2024-03-28 | 963371 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 963370 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 963369 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 963368 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 963367 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 963366 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 963365 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 963364 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 386931 | 2023-004 | Material Weakness | - | N |
| 299250 | 2023 | 2024-03-28 | 386930 | 2023-003 | Material Weakness | - | M |
| 299250 | 2023 | 2024-03-28 | 386929 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 386928 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 386927 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 386926 | 2023-002 | Significant Deficiency | - | A |
| 299250 | 2023 | 2024-03-28 | 386925 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 386924 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 386923 | 2023-001 | Significant Deficiency | - | I |
| 299250 | 2023 | 2024-03-28 | 386922 | 2023-001 | Significant Deficiency | - | I |